https://www.gosh.nhs.uk/news/a-year-of-research-impact-for-nursing-and-allied-health-professionals/
A year of research impact for nursing and allied health professionals
10 Nov 2025, 10:17 a.m.
Research at GOSH is a vibrant, inclusive space where nurses and allied health professionals (AHPs) are driving innovation, shaping policy, and transforming care for children and young people with complex health needs.
The latest annual report from the Centre for Outcomes and Experience Research in Children’s Health, Illness and Disability (ORCHID) shines a spotlight on the extraordinary contributions of these professionals. From pioneering studies to international collaborations, ORCHID is a hub of excellence that supports clinical academic careers and embeds a strong research culture across GOSH.
Empowering clinical academic careers
ORCHID champions nurses and AHPs at every stage of their research journey—whether they’re just starting out or leading major studies. Through mentorship, funding support, and strategic partnerships, the centre ensures that clinical voices are central to paediatric research.
Groundbreaking studies making a difference
This year’s report highlights a range of impactful studies led and supported by nurses and AHPs:
- SPACE Study: Exploring physical activity in children undergoing cancer treatment.
- IMPACT Study: Co-designing a chatbot to support families of children with rheumatological conditions.
- Seen and Be Heard: Addressing inequalities in cancer care for children with learning disabilities and autism.
- SPROCKET: Improving services for children with complex disabilities through systems-level innovation.
- Nursing CaRE: Investigating compassionate care delivery during the COVID-19 pandemic.
- SaFE Study: Enhancing feeding and swallowing support for children with OA/TOF.
These projects are not only advancing clinical knowledge—they’re also amplifying the voices of children, families, and frontline staff.
Recognition and reach
Staff with links to ORCHID have been recognised nationally and internationally for their work, receiving awards for innovation, leadership, and excellence in research. Their findings have been published in leading journals and presented at major conferences, including the GOSH Conference 2024, where 28 ORCHID abstracts were featured in BMJ Paediatrics Open.
ORCHID by numbers:
Fellowship income £1.6m
New research income £2m
57 peer reviewed publications
72 published abstracts
46 Conference presentations
10 PhD fellows
17 predoctoral fellows
Looking ahead
ORCHID’s strategic goals for the coming year include:
- Strengthening research leadership and mentorship.
- Promoting equitable access to research opportunities.
- Supporting career development for nurses and AHPs.
- Enhancing collaboration across disciplines and borders.
- Increasing the accessibility of research through lay summaries and creative outputs.
A culture of curiosity and compassion
At GOSH, research is making a meaningful difference in the lives of children and families. The work of nurses and AHPs within ORCHID exemplifies this ethos, combining clinical expertise with compassion, creativity, and a commitment to equity.
We are proud to celebrate their achievements and look forward to the continued impact of their work.
If you’d like to join ORCHID's monthly presentation on new and emerging research at GOSH, please email Leahana.stonier@gosh.nhs.uk
Download the full report
ORCHID Annual Report 2024 (5.1 MB)
Transport for London (TfL) strikes: May and June 2026
There are upcoming London Underground strikes planned which may affect your journey to GOSH.
Better understanding leukaemia for children with down syndrome
Researchers have mapped the evolution of a type of leukaemia that is exclusive to children with Down syndrome and may have identified an overarching weakness in the cancer's genetic makeup.
Surgeon who saved children’s sight surprised by patients, family and colleagues
Professor Chris Lloyd, consultant ophthalmic surgeon and paediatric ophthalmologist, was given a surprise to remember as a part of the BBC The One Show’s ‘One Big Thank You’.
Gentler treatment eliminates early deaths for children with relapsed leukaemia
A groundbreaking national study led by clinicians at Great Ormond Street Hospital (GOSH) has shown that children and young people with relapsed acute lymphoblastic leukaemia (ALL) can be treated safely with significantly less intensive chemotherapy.